VITASPRING BIOMEDICAL CO. LTD. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2017 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Vitaspring Biomedical Co. Ltd. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2017 to Q1 2022.
  • Vitaspring Biomedical Co. Ltd. Net Cash Provided by (Used in) Operating Activities for the quarter ending April 30, 2022 was -$28.1K, a 108% decline year-over-year.
  • Vitaspring Biomedical Co. Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2021 was $84.8K.
  • Vitaspring Biomedical Co. Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$42.1K, a 40024% decline from 2019.
  • Vitaspring Biomedical Co. Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2019 was -$105.000, a 99.7% increase from 2018.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 -$28.1K -$387K -108% Feb 1, 2022 Apr 30, 2022 10-Q 2022-06-15
Q1 2021 $359K +$358K +40086% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-15
Q1 2020 $893 -$623 -41.1% Feb 4, 2020 Apr 30, 2020 10-Q 2020-06-19
Q1 2019 $1.52K +$4.54K Feb 1, 2019 Apr 30, 2019 10-Q 2019-06-03
Q1 2018 -$3.03K -$763 -33.7% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-03
Q1 2017 -$2.27K Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.